Adolor Suffers Setback On FDA Request For More Entereg Data Nov. 7, 2006 By Aaron Lorenzo The FDA delayed approving Adolor Corp.'s Entereg (alvimopan) for postoperative ileus yet again, pending additional safety data, causing the company's shares to tumble by 44.8 percent on Monday. (BioWorld Today)Read More
